中国首台光子计数CT获批上市

Core Insights - The NeuVizP10, developed by Neusoft Medical, has received approval from the National Medical Products Administration, marking it as China's first and the world's first wide-body photon-counting CT, signifying a leap from "catching up" to "leading" in CT imaging technology [2] - Photon-counting CT is referred to as the "third revolution in CT imaging," allowing for unprecedented imaging capabilities by directly capturing and reading individual X-ray photon information, resulting in ultra-high spatial resolution, low radiation doses, and multi-energy imaging effects [2][3] Group 1: Technological Advancements - NeuVizP10 achieves an ultra-high resolution of 50 lp/cm, enabling clear visualization of extremely fine structures within the human body [3] - The device utilizes "0" electronic noise characteristics and innovative algorithms to significantly enhance image quality while reducing radiation doses and contrast agent usage, making it safer for vulnerable populations such as children, adolescents, and pregnant women [3] Group 2: Strategic Developments - In July 2024, the General Technology Group strategically invested in Neusoft Medical, indicating a shift towards greater social responsibility and mission in the healthcare sector [4] - Neusoft Medical has established deep clinical research collaborations with top-tier hospitals to explore the application potential of NeuVizP10 in complex diseases, accelerating its clinical value transformation [4] Group 3: Government Support and Industry Context - The success of NeuVizP10 is rooted in the strong support from the government for independent innovation in high-end medical equipment, with the "14th Five-Year Plan" prioritizing the development of high-end medical imaging devices [3] - The establishment of a special review procedure for innovative medical devices by the National Medical Products Administration has facilitated the accelerated approval process for NeuVizP10 [3]